Unjoni Ewropea - Malti - EMA (European Medicines Agency)

dr. falk pharma gmbh - budesonide - mard esophageal - antidiarrheals, intestinali anti-infjammatorji / antiinfective aġenti - jorveza huwa indikat għall-kura ta 'esofaġite eosinophilic (eoe) f'adulti (ta' età akbar minn 18-il sena).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarrheals, intestinali anti-infjammatorji / antiinfective aġenti - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.